Growth Metrics

Uxin (UXIN) EPS (Weighted Average and Diluted) (2017 - 2025)

Uxin filings provide 9 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.0 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 11.36% to -$0.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.0, a 101.4% decrease, with the full-year FY2025 number at -$0.0, up 87.86% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.0 in Q4 2025 for Uxin, up from -$0.14 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.17 in Q4 2021 to a low of -$872.75 in Q1 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.0 (2024), compared with a mean of -$46.62.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 804.14% in 2021 and later crashed 68231058.48% in 2023.
  • Uxin's EPS (Weighted Average and Diluted) stood at $0.17 in 2021, then tumbled by 100.0% to -$0.0 in 2022, then crashed by 68231058.48% to -$0.05 in 2023, then surged by 96.72% to -$0.0 in 2024, then increased by 11.36% to -$0.0 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.0 (Q4 2025), -$0.14 (Q3 2025), and -$0.0 (Q2 2025) per Business Quant data.